Pfizer clarifies temporary Premarin Cream supply disruption, under 1pct of revenue
PFIZER · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Pfizer told NSE that Premarin Vaginal Cream, an imported product, has been temporarily discontinued in India due to supply constraints. The company is exploring options to restore supply soon. The product contributes less than 1 percent of company revenue, so the temporary halt is not expected to have any material impact on financial performance, business operations, or profitability. Pfizer stated the discontinuation did not qualify as a material event needing disclosure under SEBI LODR rules.
Minor product contributing under 1 percent of revenue. No material hit to financials or operations expected. Stock impact likely negligible.